Applications of engineered exosomes in drugging noncoding RNAs for cancer therapy

Author:

Alemi Forough1,Sadeghsoltani Fatemeh1,Fattah Khashayar2,Hassanpour Parisa1,Malakoti Faezeh1,Kardeh Sina3,Izadpanah Melika1,de Campos Zuccari Debora Aparecida Pires4,Yousefi Bahman1ORCID,Majidinia Maryam5ORCID

Affiliation:

1. Department of Clinical Biochemistry and Laboratory Medicine, School of Medicine Tabriz University of Medical Sciences Tabriz Iran

2. School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran

3. Central Clinical School Monash University Melbourne Australia

4. Molecular Investigation of Cancer Laboratory (MICL) Faculdade de Medicina de São José do Rio Preto (FAMERP) São José do Rio Preto Brazil

5. Solid Tumor Research Center, Cellular and Molecular Medicine Institute Urmia University of Medical Sciences Urmia Iran

Abstract

AbstractNoncoding RNAs (ncRNAs) are engaged in key cell biological and pathological events, and their expression alteration is connected to cancer progression both directly and indirectly. A huge number of studies have mentioned the significant role of ncRNAs in cancer prevention and therapy that make them an interesting subject for cancer therapy. However, there are several limitations, including delivery, uptake, and short half‐life, in the application of ncRNAs in cancer treatment. Exosomes are introduced as promising options for the delivery of ncRNAs to the target cells. In this review, we will briefly discuss the application and barriers of ncRNAs. After that we will focus on exosome‐based ncRNAs delivery and their advantages as well as the latest achievements in drugging ncRNAs with exosomes.

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3